Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 226 articles: HTML format

Single Articles

July 2022
1. KROON HM, Hoogervorst LA, Hanna-Rivero N, Traeger L, et al
   Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
   Eur J Surg Oncol. 2022;48:1475-1482.
   PubMed     Abstract available
   
   
   
2. STROMBERG C, Martinez de la Maza L, Fernandez Moro C, Gerling M, et al
   Prognostic impact of inter-metastatic heterogeneity of viable tumour cells in colorectal liver metastases.
   Eur J Surg Oncol. 2022;48:1656-1663.
   PubMed     Abstract available
   
   
   
3. SUZUKI C, Halperin SK, Nilsson PJ, Martling A, et al
   Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer.
   Eur J Surg Oncol. 2022;48:1643-1649.
   PubMed     Abstract available
   
   
   
4. FUKUI Y, Hida K, Hoshino N, Song SH, et al
   Oncologic benefit of adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and curative surgery with selective lateral pelvic lymph node dissection: An international retrospective cohort study.
   Eur J Surg Oncol. 2022;48:1631-1637.
   PubMed     Abstract available
   
   
   June 2022
5. BHIMANI N, Wong GY, Molloy C, Dieng M, et al
   Cost of colorectal cancer by treatment type from different health economic perspectives: A systematic review.
   Eur J Surg Oncol. 2022 Jun 23. pii: S0748-7983(22)00528.
   PubMed     Abstract available
   
   
   
6. ZWANENBURG ES, Gehrels AM, Bastiaenen VP, Aalbers AGJ, et al
   Metachronous peritoneal metastases in patients with pT4b colon cancer: An international multicenter analysis of intraperitoneal versus retroperitoneal tumor invasion.
   Eur J Surg Oncol. 2022 Jun 11. pii: S0748-7983(22)00478.
   PubMed     Abstract available
   
   
   
7. BIRGIN E, Doyon F, Burkert J, Teoule P, et al
   Prognostic value of disease-free interval in colorectal cancer: Is it time?
   Eur J Surg Oncol. 2022 Jun 3. pii: S0748-7983(22)00485.
   PubMed     Abstract available
   
   
   
8. MOHAMED A, Nicolais L, Fitzgerald TL
   Predicting loss of independence after high-risk gastrointestinal abdominal surgery: Frailty vs. NSQIP risk calculator.
   Eur J Surg Oncol. 2022;48:1433-1438.
   PubMed     Abstract available
   
   
   
9. VAN GESTEL T, Groen LCB, Puik JR, van Rooijen SJ, et al
   Fit4Surgery for cancer patients during covid-19 lockdown - A systematic review and meta-analysis.
   Eur J Surg Oncol. 2022;48:1189-1197.
   PubMed     Abstract available
   
   
   
10. VAN DE GEEST TW, van Amerongen MJ, Nierop PMH, Hoppener DJ, et al
    Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:1368-1374.
    PubMed     Abstract available
    
    
    
11. DI MARTINO M, Dorcaratto D, Primavesi F, Syn N, et al
    Liver resection in elderly patients with extensive CRLM: Are we offering an adequate treatment? A propensity score matched analysis.
    Eur J Surg Oncol. 2022;48:1331-1338.
    PubMed     Abstract available
    
    
    
12. KETELAERS SHJ, Orsini RG, Nieuwenhuijzen GAP, Rutten HJT, et al
    Outcomes on diverting ostomy formation and reversal after low anterior resection in the older more advanced rectal cancer patient.
    Eur J Surg Oncol. 2022;48:1414-1420.
    PubMed     Abstract available
    
    
    May 2022
13. STURESSON C, Engstrand J, Stromberg C
    Reply to: The cohort data in the full pulmonary Metastasectomy in colorectal cancer study: Comment on Engstrand et al.
    Eur J Surg Oncol. 2022 May 27. pii: S0748-7983(22)00471.
    PubMed    
    
    
    
14. SCHUURMAN MS, Elferink MAG, Verhoef C, de Hingh IHJT, et al
    Peritoneal metastases in elderly patients with colorectal cancer.
    Eur J Surg Oncol. 2022 May 18. pii: S0748-7983(22)00438.
    PubMed     Abstract available
    
    
    
15. AGRAWAL A, Kazi M, Gori J, Dev I, et al
    Prospective study to assess the role of FDG PET/CT in detecting systemic metastatic spread in rectal cancers with lateral pelvic lymph nodes.
    Eur J Surg Oncol. 2022;48:1093-1099.
    PubMed     Abstract available
    
    
    
16. ABD EL AZIZ MA, McKenna NP, Jakub JW, Hallemeier CL, et al
    Rectal cancer with synchronous inguinal lymph node metastasis without distant metastasis. A call for further oncological evaluation.
    Eur J Surg Oncol. 2022;48:1100-1103.
    PubMed     Abstract available
    
    
    
17. SUKUMAR V, Kazi M, Gori J, Ankathi SK, et al
    Learning curve analysis for lateral pelvic lymph node dissection in rectal cancers - Outcomes improve with experience.
    Eur J Surg Oncol. 2022;48:1110-1116.
    PubMed     Abstract available
    
    
    
18. GIESEN LJX, Olthof PB, Elferink MAG, van Westreenen HL, et al
    Changes in rectal cancer treatment after the introduction of a national screening program; Increasing use of less invasive strategies within a national cohort.
    Eur J Surg Oncol. 2022;48:1117-1122.
    PubMed     Abstract available
    
    
    
19. VERSEVELD M, Verver D, Noordman BJ, Pouwels S, et al
    Treatment of clinical T1 rectal cancer in the Netherlands; a population-based overview of clinical practice.
    Eur J Surg Oncol. 2022;48:1153-1160.
    PubMed     Abstract available
    
    
    
20. LIM WH, Tan DJH, Ng CH, Syn N, et al
    Laparoscopic versus open resection for rectal cancer: An individual patient data meta analysis of randomized controlled trials.
    Eur J Surg Oncol. 2022;48:1133-1143.
    PubMed     Abstract available
    
    
    
21. ASSI H, Persson A, Palmquist I, Oberg M, et al
    Short-term outcomes following beyond total mesorectal excision and reconstruction using myocutaneous flaps: A retrospective cohort study.
    Eur J Surg Oncol. 2022;48:1161-1166.
    PubMed     Abstract available
    
    
    April 2022
22. STRUYS M, Ceelen W
    Incidence of lymph node recurrence after primary surgery for non-metastatic colon cancer: A systematic review.
    Eur J Surg Oncol. 2022 Apr 27. pii: S0748-7983(22)00414.
    PubMed     Abstract available
    
    
    
23. CUIJPERS ACM, Linskens FG, Bongers BC, Stassen LPS, et al
    Quality and clinical generalizability of feasibility outcomes in exercise prehabilitation before colorectal cancer surgery - A systematic review.
    Eur J Surg Oncol. 2022 Apr 23. pii: S0748-7983(22)00406.
    PubMed     Abstract available
    
    
    
24. TREASURE T, Williams NR, Macbeth F
    The cohort data in the full pulmonary metastasectomy in colorectal cancer study: Comment on Engstrand et al.
    Eur J Surg Oncol. 2022 Apr 23. pii: S0748-7983(22)00408.
    PubMed    
    
    
    
25. PEDRAZZANI C, Kim HJ, Park EJ, Turri G, et al
    Does laparoscopy increase the risk of peritoneal recurrence after resection for pT4 colon cancer? Results of a propensity score-matched analysis from an international cohort.
    Eur J Surg Oncol. 2022 Apr 22. pii: S0748-7983(22)00409.
    PubMed     Abstract available
    
    
    
26. CHAN AK, Ignatowicz AM, Mason JM, Siriwardena AK, et al
    Colorectal cancer and synchronous liver metastases: An individual case-based qualitative study (CoSMIC-Q).
    Eur J Surg Oncol. 2022 Apr 14. pii: S0748-7983(22)00385.
    PubMed     Abstract available
    
    
    
27. BOOME IT, Somers AMJ, Graupner C, Kimman ML, et al
    Development and content validation of the Assessment of Burden of ColoRectal Cancer (ABCRC)-tool.
    Eur J Surg Oncol. 2022 Apr 7. pii: S0748-7983(22)00379.
    PubMed     Abstract available
    
    
    
28. NORS J, Iversen LH, Nielsen K, Sorensen MM, et al
    Peritoneal metastases found in routinely resected specimens after cytoreductive surgery and heated intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2022;48:795-802.
    PubMed     Abstract available
    
    
    
29. O'CONNELL E, McDevitt J, Hill ADK, McNamara DA, et al
    Centralisation of rectal cancer care has improved patient survival in the republic of Ireland.
    Eur J Surg Oncol. 2022;48:890-895.
    PubMed     Abstract available
    
    
    
30. HORIE K, Matsuda T, Yamashita K, Hasegawa H, et al
    Sarcopenia assessed by skeletal muscle mass volume is a prognostic factor for oncological outcomes of rectal cancer patients undergoing neoadjuvant chemoradiotherapy followed by surgery.
    Eur J Surg Oncol. 2022;48:850-856.
    PubMed     Abstract available
    
    
    
31. CHEN Q, Chen J, Huang Z, Zhao H, et al
    Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
    Eur J Surg Oncol. 2022;48:864-872.
    PubMed     Abstract available
    
    
    
32. FOPPA C, Tamburello S, Maroli A, Carvello M, et al
    Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients.
    Eur J Surg Oncol. 2022;48:857-863.
    PubMed     Abstract available
    
    
    
33. KRUL MF, Gerritsen SL, Vissers FL, Klompenhouwer EG, et al
    Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:834-840.
    PubMed     Abstract available
    
    
    March 2022
34. PRING ET, Malietzis G, Gould LE, Lung P, et al
    Tumour grade and stage are associated with specific body composition phenotypes with visceral obesity predisposing the host to a less aggressive tumour in colorectal cancer.
    Eur J Surg Oncol. 2022 Mar 19. pii: S0748-7983(22)00134.
    PubMed     Abstract available
    
    
    
35. ENGSTRAND J, Sterner J, Hasselgren K, Stromberg C, et al
    Treatment intention and outcome in patients with simultaneously diagnosed liver and lung metastases from colorectal cancer.
    Eur J Surg Oncol. 2022 Mar 11. pii: S0748-7983(22)00128.
    PubMed     Abstract available
    
    
    
36. MADONIA D, Graf W, Ghanipour L
    The incidence and prognostic importance of ovarian involvement in patients with peritoneal metastasis undergoing CRS-HIPEC.
    Eur J Surg Oncol. 2022;48:666-671.
    PubMed     Abstract available
    
    
    
37. BAJRIC T, Kornprat P, Faschinger F, Werkgartner G, et al
    Sarcopenia and primary tumor location influence patients outcome after liver resection for colorectal liver metastases.
    Eur J Surg Oncol. 2022;48:615-620.
    PubMed     Abstract available
    
    
    February 2022
38. MC ENTEE PD, Shokuhi P, Rogers AC, Mehigan BJ, et al
    Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death.
    Eur J Surg Oncol. 2022 Feb 19. pii: S0748-7983(22)00090.
    PubMed     Abstract available
    
    
    
39. SARJANOJA E, Klintrup K, Ohtonen P, Kauppila JH, et al
    Annual hospital volume and colorectal cancer survival in a population-based nationwide cohort study in Finland.
    Eur J Surg Oncol. 2022 Feb 18. pii: S0748-7983(22)00111.
    PubMed     Abstract available
    
    
    
40. SUGARBAKER PH, Chang D
    Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators.
    Eur J Surg Oncol. 2022 Feb 3. pii: S0748-7983(22)00074.
    PubMed     Abstract available
    
    
    
41. UEDA K, Yamada T, Ohta R, Matsuda A, et al
    BRAF V600E mutations in right-side colon cancer: Heterogeneity detected by liquid biopsy.
    Eur J Surg Oncol. 2022 Feb 2. pii: S0748-7983(22)00042.
    PubMed     Abstract available
    
    
    
42. ELFRINK AKE, Kok NFM, Swijnenburg RJ, den Dulk M, et al
    Nationwide oncological networks for resection of colorectal liver metastases in the Netherlands: Differences and postoperative outcomes.
    Eur J Surg Oncol. 2022;48:435-448.
    PubMed     Abstract available
    
    
    
43. AMROUN K, Scholer V, Djerada Z, Renard Y, et al
    Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.
    Eur J Surg Oncol. 2022;48:455-461.
    PubMed     Abstract available
    
    
    
44. VAN 'T SANT I, Nerad E, Rijsemus CJV, Engbersen MP, et al
    Seeing the whole picture: Added value of MRI for extraperitoneal findings in CRS-HIPEC candidates.
    Eur J Surg Oncol. 2022;48:462-469.
    PubMed     Abstract available
    
    
    January 2022
45. CHO HJ, Lee IK, Lee YS, Yun SS, et al
    Application of venous thromboembolism prophylaxis program in patients with colorectal cancer using the enhanced recovery after surgery protocol.
    Eur J Surg Oncol. 2022 Jan 31. pii: S0748-7983(22)00048.
    PubMed     Abstract available
    
    
    
46. SUGARBAKER PH, Chang D
    Anatomic sites of disease in colorectal cancer patients recorded at the time of cytoreductive surgery for peritoneal metastases.
    Eur J Surg Oncol. 2022 Jan 13. pii: S0748-7983(22)00011.
    PubMed     Abstract available
    
    
    
47. VAN DORP M, Bousema JE, Torensma B, Dickhoff C, et al
    Pulmonary metastasectomy with lymphadenectomy for colorectal pulmonary metastases: A systematic review.
    Eur J Surg Oncol. 2022;48:253-260.
    PubMed     Abstract available
    
    
    
48. NG L, Li X, Wan TM, Iyer D, et al
    Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells.
    Eur J Surg Oncol. 2022;48:245-252.
    PubMed     Abstract available
    
    
    
49. BOGVERADZE N, Lambregts DMJ, El Khababi N, Dresen RC, et al
    The sigmoid take-off as a landmark to distinguish rectal from sigmoid tumours on MRI: Reproducibility, pitfalls and potential impact on treatment stratification.
    Eur J Surg Oncol. 2022;48:237-244.
    PubMed     Abstract available
    
    
    
50. MORAIS M, Pinto DM, Machado JC, Carneiro S, et al
    ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review.
    Eur J Surg Oncol. 2022;48:218-227.
    PubMed     Abstract available
    
    
    
51. ASSAF D, Mor E, Laks S, Zohar N, et al
    The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
    Eur J Surg Oncol. 2022;48:197-203.
    PubMed     Abstract available
    
    
    
52. MA SM, Dong J, Liang L, Liu XT, et al
    The prognostic and clinicopathological roles of microsatellite instability, PD-L1 expression and tumor-infiltrating leukocytes in familial adenomatous polyposis.
    Eur J Surg Oncol. 2022;48:211-217.
    PubMed     Abstract available
    
    
    
53. VERWAAL VJ, Funder JA, Sorensen MM, Iversen LH, et al
    The impact of postoperative complications following cytoreductive surgery combined with oxaliplatin based heated intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2022;48:183-187.
    PubMed     Abstract available
    
    
    
54. VILLAMONTE M, Burdio F, Pueyo E, Andaluz A, et al
    The impact of additional margin coagulation with radiofrequency in liver resections with subcentimetric margin: can we improve the oncological results? A propensity score matching study.
    Eur J Surg Oncol. 2022;48:82-88.
    PubMed     Abstract available
    
    
    December 2021
55. DUMONT F, Guenole S, Loaec C, Bourgin C, et al
    Survival after cytoreductive surgery for peritoneal metastases in colorectal cancer patients: Does a history of resected liver metastases worsen the prognosis?
    Eur J Surg Oncol. 2021 Dec 22. pii: S0748-7983(21)00995.
    PubMed     Abstract available
    
    
    
56. MEYER Y, Olthof PB, Grunhagen DJ, de Hingh I, et al
    Treatment of metachronous colorectal cancer metastases in the Netherlands: A population-based study.
    Eur J Surg Oncol. 2021 Dec 4. pii: S0748-7983(21)00951.
    PubMed     Abstract available
    
    
    
57. PIOZZI GN, Rusli SM, Baek SJ, Kwak JM, et al
    Infrapyloric and gastroepiploic node dissection for hepatic flexure and transverse colon cancer: A systematic review.
    Eur J Surg Oncol. 2021 Dec 4. pii: S0748-7983(21)00952.
    PubMed     Abstract available
    
    
    
58. BOSMA NA, Keehn AR, Lee-Ying R, Karim S, et al
    Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021;47:3113-3122.
    PubMed     Abstract available
    
    
    
59. SPINELLI A, Foppa C, Carvello M, Sacchi M, et al
    Transanal Transection and Single-Stapled Anastomosis (TTSS): A comparison of anastomotic leak rates with the double-stapled technique and with transanal total mesorectal excision (TaTME) for rectal cancer.
    Eur J Surg Oncol. 2021;47:3123-3129.
    PubMed     Abstract available
    
    
    
60. WANG Z, Liu Z, Wen Z, Li R, et al
    Evaluation of radical surgical treatment in the management of 58 locally advanced rectal neuroendocrine neoplasms, one multicenter retrospective study.
    Eur J Surg Oncol. 2021;47:3166-3174.
    PubMed     Abstract available
    
    
    
61. AKIYOSHI T, Yamaguchi T, Hiratsuka M, Mukai T, et al
    Oncologic impact of lateral lymph node metastasis at the distal lateral compartment in locally advanced low rectal cancer after neoadjuvant (chemo)radiotherapy.
    Eur J Surg Oncol. 2021;47:3157-3165.
    PubMed     Abstract available
    
    
    
62. ZHENG Z, Wang X, Liu Z, Lu X, et al
    Individualized conditional survival nomograms for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and radical surgery.
    Eur J Surg Oncol. 2021;47:3175-3181.
    PubMed     Abstract available
    
    
    November 2021
63. BENAVIDES M, Gomez-Espana A, Garcia-Alfonso P, Gonzalez CG, et al
    Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
    Eur J Surg Oncol. 2021 Nov 25. pii: S0748-7983(21)00931.
    PubMed     Abstract available
    
    
    
64. WARPS AK, Tollenaar RAEM, Tanis PJ, Dekker JWT, et al
    Postoperative complications after colorectal cancer surgery and the association with long-term survival.
    Eur J Surg Oncol. 2021 Nov 11. pii: S0748-7983(21)00785.
    PubMed     Abstract available
    
    
    
65. DE NES LCF, van der Heijden JAG, Verstegen MG, Drager L, et al
    Predictors of undergoing multivisceral resection, margin status and survival in Dutch patients with locally advanced colorectal cancer.
    Eur J Surg Oncol. 2021 Nov 6. pii: S0748-7983(21)00789.
    PubMed     Abstract available
    
    
    
66. WARPS AK, Detering R, Tollenaar RAEM, Tanis PJ, et al
    Textbook outcome after rectal cancer surgery as a composite measure for quality of care: A population-based study.
    Eur J Surg Oncol. 2021;47:2821-2829.
    PubMed     Abstract available
    
    
    
67. GUERRA F, Petrelli F, Greco PA, Sisti V, et al
    The impact of synchronous liver resection on the risk of anastomotic leakage following elective colorectal resection. A propensity score match analysis on behalf of the iCral study group.
    Eur J Surg Oncol. 2021;47:2873-2879.
    PubMed     Abstract available
    
    
    
68. LJUNGGREN M, Nordenvall C, Palmer G
    Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
    Eur J Surg Oncol. 2021;47:2865-2872.
    PubMed     Abstract available
    
    
    
69. GAU L, Ribeiro M, Pereira B, Poirot K, et al
    Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis.
    Eur J Surg Oncol. 2021;47:2722-2733.
    PubMed     Abstract available
    
    
    
70. BAE HW, Kim HS, Yang SY, Kim HS, et al
    Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases.
    Eur J Surg Oncol. 2021;47:2814-2820.
    PubMed     Abstract available
    
    
    
71. VAN DE VLASAKKER VCJ, Lurvink RJ, Cashin PH, Ceelen W, et al
    The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).
    Eur J Surg Oncol. 2021;47:2888-2892.
    PubMed     Abstract available
    
    
    October 2021
72. DI GIORGIO A, Rotolo S, Cintoni M, Rinninella E, et al
    The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021 Oct 16. pii: S0748-7983(21)00763.
    PubMed     Abstract available
    
    
    
73. HODGES N, Mackenzie H, D'Souza N, Brown G, et al
    Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort study.
    Eur J Surg Oncol. 2021 Oct 16. pii: S0748-7983(21)00760.
    PubMed     Abstract available
    
    
    
74. GALEMA HA, Meijer RPJ, Lauwerends LJ, Verhoef C, et al
    Fluorescence-guided surgery in colorectal cancer; A review on clinical results and future perspectives.
    Eur J Surg Oncol. 2021 Oct 9. pii: S0748-7983(21)00755.
    PubMed     Abstract available
    
    
    
75. KATAOKA K, Yamada T, Taniguchi H, Ikeda M, et al
    A ctDNA-driven multidisciplinary treatment strategy for resectable colorectal cancer -what surgical oncologists should know.
    Eur J Surg Oncol. 2021 Oct 7. pii: S0748-7983(21)00752.
    PubMed    
    
    
    
76. FIORICA F, Napoli G, Berretta M, Soliani G, et al
    Letter to editor: A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
    Eur J Surg Oncol. 2021;47:2700-2701.
    PubMed    
    
    
    
77. YUKSEL BC
    Comment on 'Local recurrence in sigmoid cancer is a hidden problem, could CT prognostic factors be of value in their prevention? A multi-centre study of 414 patients'.
    Eur J Surg Oncol. 2021;47:2696.
    PubMed    
    
    
    
78. CLANCY C, Martin ST
    Reply to: Commentary to "A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours".
    Eur J Surg Oncol. 2021;47:2702-2703.
    PubMed    
    
    
    
79. GIGLIO MC, Garofalo E, Montalti R, Vanlander A, et al
    The learning curve of laparoscopic ablation of liver tumors: A technically demanding procedure requiring dedicated training.
    Eur J Surg Oncol. 2021;47:2579-2585.
    PubMed     Abstract available
    
    
    September 2021
80. PEI JP, Zhao ZM, Sun Z, Gu WJ, et al
    Development and validation of a novel classification scheme for combining pathological T stage and log odds of positive lymph nodes for colon cancer.
    Eur J Surg Oncol. 2021 Sep 9. pii: S0748-7983(21)00728.
    PubMed     Abstract available
    
    
    
81. KROON HM, Kusters M, Chang GJ, Sammour T, et al
    Reply to: Lateral lymph node dissection in low rectal cancers: Call for standardized reporting of results to unify the global practice.
    Eur J Surg Oncol. 2021;47:2477-2478.
    PubMed    
    
    
    
82. PATEL S, Kazi M, Saklani A
    Lateral lymph node dissection in low rectal cancers: Call for standardized reporting of results to unify the global practice.
    Eur J Surg Oncol. 2021;47:2475-2476.
    PubMed    
    
    
    
83. VOOGT ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, et al
    Reply to: Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
    Eur J Surg Oncol. 2021;47:2473-2474.
    PubMed    
    
    
    
84. PATEL S, Prem A, Raghavan S
    Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
    Eur J Surg Oncol. 2021;47:2472.
    PubMed    
    
    
    
85. DAY N
    Reply to: CT defined prognostic factors for local recurrence after sigmoid resection - How relevant are they?
    Eur J Surg Oncol. 2021;47:2467.
    PubMed    
    
    
    
86. KROON HM, Malakorn S, Dudi-Venkata NN, Bedrikovetski S, et al
    Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Eur J Surg Oncol. 2021;47:2441-2449.
    PubMed     Abstract available
    
    
    
87. MARIATHASAN AB, Boye K, Dueland S, Flatmark K, et al
    Metastases in locally advanced rectal cancer undergoing curatively intended treatment.
    Eur J Surg Oncol. 2021;47:2377-2383.
    PubMed     Abstract available
    
    
    
88. VOOGT ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, et al
    Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
    Eur J Surg Oncol. 2021;47:2429-2435.
    PubMed     Abstract available
    
    
    
89. FAHIM M, Dijksman LM, Derksen WJM, Bloemen JG, et al
    Prospective multicentre study of a new bowel obstruction treatment in colorectal surgery: Reduced morbidity and mortality.
    Eur J Surg Oncol. 2021;47:2414-2420.
    PubMed     Abstract available
    
    
    
90. MORARASU S, O'Brien L, Clancy C, Dietrich D, et al
    A systematic review and meta-analysis comparing surgical and oncological outcomes of upper rectal, rectosigmoid and sigmoid tumours.
    Eur J Surg Oncol. 2021;47:2421-2428.
    PubMed     Abstract available
    
    
    
91. KAZI M, Saklani A
    CT defined prognostic factors for local recurrence after sigmoid resection - How relevant are they?
    Eur J Surg Oncol. 2021;47:2465-2466.
    PubMed    
    
    
    
92. GIESEN LJX, Olthof PB, Elferink MAG, Verhoef C, et al
    Surgery for rectal cancer: Differences in resection rates among hospitals in the Netherlands.
    Eur J Surg Oncol. 2021;47:2384-2389.
    PubMed     Abstract available
    
    
    
93. CALINI G, Abd El Aziz MA, Abdalla S, Saeed HA, et al
    Patient colon and rectal operative outcomes when treated with immune checkpoint inhibitors.
    Eur J Surg Oncol. 2021;47:2436-2440.
    PubMed     Abstract available
    
    
    August 2021
94. LIN Y, Sun Y, Lin H, Huang Y, et al
    Prediction of prolonged resolution of chylous ascites after radical D3 resection for colorectal cancer: A population-based experience from a high-volume center.
    Eur J Surg Oncol. 2021 Aug 24. pii: S0748-7983(21)00700.
    PubMed     Abstract available
    
    
    
95. DASTER S, Shin JS, Loizides S, Steffens D, et al
    Pathology reporting of pelvic exenteration specimens for locally recurrent rectal cancer.
    Eur J Surg Oncol. 2021;47:2100-2107.
    PubMed     Abstract available
    
    
    
96. DAY N, D'Souza N, Shaw A, Lord A, et al
    Local recurrence in sigmoid cancer is a hidden problem, could CT prognostic factors be of value in their prevention? A multi-centre study of 414 patients.
    Eur J Surg Oncol. 2021;47:2093-2099.
    PubMed     Abstract available
    
    
    
97. LI K, He X, Tong S, Zheng Y, et al
    Risk factors for sexual dysfunction after rectal cancer surgery in 948 consecutive patients: A prospective cohort study.
    Eur J Surg Oncol. 2021;47:2087-2092.
    PubMed     Abstract available
    
    
    
98. WILSON K, Flood M, Narasimhan V, Pham T, et al
    Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: A systematic review.
    Eur J Surg Oncol. 2021;47:1862-1874.
    PubMed     Abstract available
    
    
    
99. KLOSE J, Schmitt A, Pernthaler J, Warschkow R, et al
    Still proliferating CD44(+)/Ki67(+) tumor cells after neoadjuvant radiochemotherapy identify rectal cancer patients with poor survival.
    Eur J Surg Oncol. 2021;47:2078-2086.
    PubMed     Abstract available
    
    
    
100. PIOZZI GN, Park H, Lee TH, Kim JS, et al
     Risk factors for local recurrence and long term survival after minimally invasive intersphincteric resection for very low rectal cancer: Multivariate analysis in 161 patients.
     Eur J Surg Oncol. 2021;47:2069-2077.
     PubMed     Abstract available
     
     
     
101. LANCELLOTTI F, Solinas L, Sagnotta A, Mancini S, et al
     Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
     Eur J Surg Oncol. 2021;47:2046-2052.
     PubMed     Abstract available
     
     
     
102. VILLARD C, Habib M, Nordenvall C, Nilsson PJ, et al
     Conversion therapy in patients with colorectal liver metastases.
     Eur J Surg Oncol. 2021;47:2038-2045.
     PubMed     Abstract available
     
     
     July 2021
103. SATO Y, Satoyoshi T, Okita K, Kyuno D, et al
     Snapshots of lymphatic pathways in colorectal cancer surgery using near-infrared fluorescence, in vivo and ex vivo.
     Eur J Surg Oncol. 2021 Jul 31. pii: S0748-7983(21)00646.
     PubMed     Abstract available
     
     
     
104. VAN DER VLIES E, Vernooij LM, van Erning FN, Vink GR, et al
     Survival of surgical and non-surgical older patients with non-metastatic colorectal cancer: A population-based study in the Netherlands.
     Eur J Surg Oncol. 2021 Jul 26. pii: S0748-7983(21)00639.
     PubMed     Abstract available
     
     
     
105. OHTA R, Yamada T, Sonoda H, Matsuda A, et al
     Detection of KRAS mutations in circulating tumour DNA from plasma and urine of patients with colorectal cancer.
     Eur J Surg Oncol. 2021 Jul 22. pii: S0748-7983(21)00638.
     PubMed     Abstract available
     
     
     
106. KIM JC, Kim CW, Lee JL, Yoon YS, et al
     Complete intersphincteric longitudinal muscle excision May Be key to reducing local recurrence during intersphincteric resection.
     Eur J Surg Oncol. 2021;47:1629-1636.
     PubMed     Abstract available
     
     
     
107. DU R, Zhou J, Tong G, Chang Y, et al
     Postoperative morbidity and mortality after anterior resection with preventive diverting loop ileostomy versus loop colostomy for rectal cancer: A updated systematic review and meta-analysis.
     Eur J Surg Oncol. 2021;47:1514-1525.
     PubMed     Abstract available
     
     
     
108. DENOST Q, Assenat V, Vendrely V, Celerier B, et al
     Oncological strategy following R1 sphincter-saving resection in low rectal cancer after chemoradiotherapy.
     Eur J Surg Oncol. 2021;47:1683-1690.
     PubMed     Abstract available
     
     
     
109. WANG T, Zhao Y, Wang M, Zhang P, et al
     Radical resection versus local excision for low rectal gastrointestinal stromal tumor: A multicenter propensity score-matched analysis.
     Eur J Surg Oncol. 2021;47:1668-1674.
     PubMed     Abstract available
     
     
     
110. VAN REES JM, Hoppener DJ, Hagemans JAW, Rothbarth J, et al
     The clinical relevance of indeterminate lung nodules in patients with locally recurrent rectal cancer.
     Eur J Surg Oncol. 2021;47:1616-1622.
     PubMed     Abstract available
     
     
     June 2021
111. BASTIAENEN VP, Tanis PJ
     Reply to: Peritoneal invasion and metachronous peritoneal metastases after colon cancer surgery: The role of homogeneous, reliable assessment and confounders.
     Eur J Surg Oncol. 2021 Jun 30. pii: S0748-7983(21)00595.
     PubMed    
     
     
     
112. PELLINO G, Garcia-Granero E, Cervantes A
     Peritoneal invasion and metachronous peritoneal metastases after colon cancer surgery: The role of homogeneous, reliable assessment and confounders.
     Eur J Surg Oncol. 2021 Jun 29. pii: S0748-7983(21)00596.
     PubMed    
     
     
     
113. VAN DEN BROEK JJ, van Gestel T, Kol SQ, van Geel AM, et al
     Dealing with indeterminate pulmonary nodules in colorectal cancer patients; a systematic review.
     Eur J Surg Oncol. 2021 Jun 6. pii: S0748-7983(21)00538.
     PubMed     Abstract available
     
     
     
114. SONG I, Park JW, Lim HK, Kim MJ, et al
     The oncologic safety of left colectomy with modified complete mesocolic excision for distal transverse colon cancer: Comparison with descending colon cancer.
     Eur J Surg Oncol. 2021 Jun 6. pii: S0748-7983(21)00545.
     PubMed     Abstract available
     
     
     
115. VAN DER HULST HC, Bastiaannet E, Portielje JEA, van der Bol JM, et al
     Can physical prehabilitation prevent complications after colorectal cancer surgery in frail older patients?
     Eur J Surg Oncol. 2021 Jun 3. pii: S0748-7983(21)00539.
     PubMed     Abstract available
     
     
     
116. SONODA H, Yamada T, Matsuda A, Ohta R, et al
     Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
     Eur J Surg Oncol. 2021 Jun 2. pii: S0748-7983(21)00536.
     PubMed     Abstract available
     
     
     
117. KASTORA SL, Osborne LL, Jardine R, Kounidas G, et al
     Non-steroidal anti-inflammatory agents and anastomotic leak rates across colorectal cancer operations and anastomotic sites: A systematic review and meta-analysis of anastomosis specific leak rate and confounding factors.
     Eur J Surg Oncol. 2021 Jun 1. pii: S0748-7983(21)00535.
     PubMed     Abstract available
     
     
     
118. ZAAT AS, Schreurs HWH
     Letter to the editor: "Postoperative administration of non-steroidal anti-inflammatory drugs in colorectal cancer surgery does not increase anastomotic leak rate; A systematic review and meta-analyse".
     Eur J Surg Oncol. 2021 Jun 1. pii: S0748-7983(21)00523.
     PubMed    
     
     
     
119. KAECH M, Deutschmann E, Moffa G, Haak F, et al
     Influence of the introduction of caseload requirements on indication for visceral cancer surgery in Switzerland.
     Eur J Surg Oncol. 2021;47:1324-1331.
     PubMed     Abstract available
     
     
     
120. CLIFFORD RE, Gerrard AD, Fok M, Vimalachandran D, et al
     Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature.
     Eur J Surg Oncol. 2021;47:1252-1257.
     PubMed     Abstract available
     
     
     
121. ARJONA-SANCHEZ A, Aziz O, Passot G, Salti G, et al
     Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.
     Eur J Surg Oncol. 2021;47:1420-1426.
     PubMed     Abstract available
     
     
     May 2021
122. DE KLERK M, van Dalen DH, Nahar-van Venrooij LMW, Meijerink WJHJ, et al
     A multimodal prehabilitation program in high-risk patients undergoing elective resection for colorectal cancer: A retrospective cohort study.
     Eur J Surg Oncol. 2021 May 29. pii: S0748-7983(21)00528.
     PubMed     Abstract available
     
     
     
123. ARRON MNN
     Reply to: Letter to the editor: ''Postoperative administration of non-steroidal anti-inflammatory drugs in colorectal cancer surgery does not increase anastomotic leak rate; a systematic review and meta-analysis''.
     Eur J Surg Oncol. 2021 May 27. pii: S0748-7983(21)00520.
     PubMed    
     
     
     
124. CHESNEY TR, Metz JJ, Nadler A, Quereshy FA, et al
     Long-term outcomes of resection for locoregional recurrence of colon cancer: A retrospective descriptive cohort study.
     Eur J Surg Oncol. 2021 May 19. pii: S0748-7983(21)00479.
     PubMed     Abstract available
     
     
     
125. BASTIAENEN VP, Aalbers AGJ, Arjona-Sanchez A, Bellato V, et al
     Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
     Eur J Surg Oncol. 2021 May 15. pii: S0748-7983(21)00485.
     PubMed     Abstract available
     
     
     
126. ROSANDER E, Holm T, Sjovall A, Hjern F, et al
     Preoperative multidisciplinary team assessment is associated with improved survival in patients with locally advanced colon cancer; a nationwide cohort study in 3157 patients.
     Eur J Surg Oncol. 2021 May 14. pii: S0748-7983(21)00484.
     PubMed     Abstract available
     
     
     
127. YE J, Tian Y, Li F, van Oostendorp S, et al
     Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: A case matched study.
     Eur J Surg Oncol. 2021;47:1019-1025.
     PubMed     Abstract available
     
     
     
128. MEILLAT H, Braticevic C, Zemmour C, Brun C, et al
     Real-world implementation of a geriatric-specific ERAS protocol in patients undergoing colonic cancer surgery.
     Eur J Surg Oncol. 2021;47:1012-1018.
     PubMed     Abstract available
     
     
     
129. OGURA A, Uehara K, Aiba T, Sando M, et al
     Indications for neoadjuvant treatment based on risk factors for poor prognosis before and after neoadjuvant chemotherapy alone in patients with locally advanced rectal cancer.
     Eur J Surg Oncol. 2021;47:1005-1011.
     PubMed     Abstract available
     
     
     
130. STERPETTI AV, Marzo LD, Sapienza P
     Risk factors for adenocarcinoma in the surgically transposed colon not exposed to the fecal stream. Etiological considerations extrapolated to sporadic colon carcinoma in the general population.
     Eur J Surg Oncol. 2021;47:931-934.
     PubMed     Abstract available
     
     
     
131. GAO TM, Bai DS, Qian JJ, Zhang C, et al
     Real-world clinical significance of nonbiological factors with staging, prognosis and clinical management in rectal cancer.
     Eur J Surg Oncol. 2021;47:990-998.
     PubMed     Abstract available
     
     
     April 2021
132. WESTBERG K, Othman B, Suzuki C, Blomqvist L, et al
     Magnetic resonance imaging as a predictor of surgical outcome in patients with local pelvic recurrence of colorectal cancer.
     Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00449.
     PubMed     Abstract available
     
     
     
133. GILLIS C, Fenton TR, Gramlich L, Sajobi TT, et al
     Older frail prehabilitated patients who cannot attain a 400 m 6-min walking distance before colorectal surgery suffer more postoperative complications.
     Eur J Surg Oncol. 2021;47:874-881.
     PubMed     Abstract available
     
     
     
134. SCHULLIAN P, Johnston EW, Putzer D, Laimer G, et al
     Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
     Eur J Surg Oncol. 2021;47:866-873.
     PubMed     Abstract available
     
     
     
135. CONCI S, Ruzzenente A, Pedrazzani C, Isa G, et al
     Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes.
     Eur J Surg Oncol. 2021;47:842-849.
     PubMed     Abstract available
     
     
     
136. ASSI H, Persson A, Palmquist I, Oberg M, et al
     Sexual and functional long-term outcomes following advanced pelvic cancer and reconstruction using vertical rectus abdominis myocutaneous and gluteal myocutaneous flap.
     Eur J Surg Oncol. 2021;47:858-865.
     PubMed     Abstract available
     
     
     March 2021
137. EGENVALL M, Martling A, Veres K, Horvath-Puho E, et al
     No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial.
     Eur J Surg Oncol. 2021 Mar 26. pii: S0748-7983(21)00377.
     PubMed     Abstract available
     
     
     
138. VAN DEN BERG I, van de Weerd S, van Klaveren D, Coebergh van den Braak RRJ, et al
     Daily practice in guideline adherence to adjuvant chemotherapy in stage III colon cancer and predictors of outcome.
     Eur J Surg Oncol. 2021 Mar 16. pii: S0748-7983(21)00376.
     PubMed     Abstract available
     
     
     
139. ELFRINK AKE, van Zwet EW, Swijnenburg RJ, den Dulk M, et al
     Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastases.
     Eur J Surg Oncol. 2021;47.
     PubMed     Abstract available
     
     
     
140. MEIJER RPJ, de Valk KS, Deken MM, Boogerd LSF, et al
     Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA.
     Eur J Surg Oncol. 2021;47.
     PubMed     Abstract available
     
     
     February 2021
141. BALCISCUETA Z, Balciscueta I, Uribe N, Pellino G, et al
     D3-lymphadenectomy enhances oncological clearance in patients with right colon cancer. Results of a meta-analysis.
     Eur J Surg Oncol. 2021 Feb 26. pii: S0748-7983(21)00111.
     PubMed     Abstract available
     
     
     
142. LOAEC C, Guerin-Charbonnel C, Vignaud T, Paineau J, et al
     Individual learning curve of cytoreductive surgery for peritoneal metastasis from colorectal cancer: A process with an impact on survival.
     Eur J Surg Oncol. 2021 Feb 16. pii: S0748-7983(21)00106.
     PubMed     Abstract available
     
     
     
143. SCHEEPERS ERM, Schiphorst AH, van Huis-Tanja LH, Emmelot-Vonk MH, et al
     Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer.
     Eur J Surg Oncol. 2021 Feb 3. pii: S0748-7983(21)00059.
     PubMed     Abstract available
     
     
     
144. REPULLO DJ, Barbois S, Leonard D, Bohlok A, et al
     The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis.
     Eur J Surg Oncol. 2021 Feb 3. pii: S0748-7983(21)00048.
     PubMed     Abstract available
     
     
     
145. RYAN OK, Ryan EJ, Creavin B, Rausa E, et al
     Surgical approach for rectal cancer: A network meta-analysis comparing open, laparoscopic, robotic and transanal TME approaches.
     Eur J Surg Oncol. 2021;47:285-295.
     PubMed     Abstract available
     
     
     
146. PELLINO G, Alos R, Biondo S, Codina-Cazador A, et al
     Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project.
     Eur J Surg Oncol. 2021;47:276-284.
     PubMed     Abstract available
     
     
     
147. ACHILLI P, Radtke TS, Lovely JK, Behm KT, et al
     Preoperative predictive risk to cancer quality in robotic rectal cancer surgery.
     Eur J Surg Oncol. 2021;47:317-322.
     PubMed     Abstract available
     
     
     
148. KNIGHT K, Al-Wahid M, Choong JX, Burton K, et al
     Multidisciplinary management of anal intraepithelial neoplasia and rate of progression to cancer: A retrospective cohort study.
     Eur J Surg Oncol. 2021;47:304-310.
     PubMed     Abstract available
     
     
     
149. OKUNO M, Kawaguchi Y, De Bellis M, Vega EA, et al
     A new sequential treatment strategy for multiple colorectal liver metastases: Planned incomplete resection and postoperative completion ablation for intentionally-untreated tumors under guidance of cross-sectional imaging.
     Eur J Surg Oncol. 2021;47:311-316.
     PubMed     Abstract available
     
     
     
150. SCHERMAN P, Syk I, Holmberg E, Naredi P, et al
     Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study.
     Eur J Surg Oncol. 2021;47:375-383.
     PubMed     Abstract available
     
     
     
151. DE PAUL TR, Augestad KM, Kiran RP, Keller DS, et al
     Management of the positive pathologic circumferential resection margin in rectal cancer: A national cancer database (NCDB) study.
     Eur J Surg Oncol. 2021;47:296-303.
     PubMed     Abstract available
     
     
     January 2021
152. BAHADOER RR, Bastiaannet E, Claassen YHM, van der Mark M, et al
     One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison.
     Eur J Surg Oncol. 2021 Jan 21. pii: S0748-7983(21)00037.
     PubMed     Abstract available
     
     
     
153. YOU K, Park HC, Park SC, Sohn DK, et al
     Laparoscopic approach for T4 colon cancer can be associated with poor prognosis in right-sided T4b tumours.
     Eur J Surg Oncol. 2021 Jan 20. pii: S0748-7983(21)00035.
     PubMed     Abstract available
     
     
     
154. BHOME R, Peppa N, Karar S, McDonnell D, et al
     Metabolic syndrome is a predictor of all site and liver-specific recurrence following primary resection of colorectal cancer: Prospective cohort study of 1006 patients.
     Eur J Surg Oncol. 2021 Jan 7. pii: S0748-7983(20)31237.
     PubMed     Abstract available
     
     
     
155. QADERI SM, Swartjes H, Vromen H, Bremers AJA, et al
     Acceptability, quality of life and cost overview of a remote follow-up plan for patients with colorectal cancer.
     Eur J Surg Oncol. 2021 Jan 5. pii: S0748-7983(20)31239.
     PubMed     Abstract available
     
     
     
156. SOMMARIVA A, Ansaloni L, Baiocchi GL, Cascinu S, et al
     Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology.
     Eur J Surg Oncol. 2021;47:164-171.
     PubMed     Abstract available
     
     
     
157. FROYSNES IS, Andersson Y, Larsen SG, Davidson B, et al
     ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis.
     Eur J Surg Oncol. 2021;47:134-138.
     PubMed     Abstract available
     
     
     December 2020
158. VUTHALURU S, Jain M, Seenu V
     Letter to Editor- Minimally invasive surgery for T4 colon cancer is associated with better outcomes than open surgery in National Cancer Database.
     Eur J Surg Oncol. 2020 Dec 5. pii: S0748-7983(20)31038.
     PubMed    
     
     
     
159. PANDEY D, Rohila J, Sukumar V, Saklani A, et al
     The impact of circumferential tumor location on the clinical outcomes of rectal cancers receiving neoadjuvant chemoradiation and surgery-does it really matter?
     Eur J Surg Oncol. 2020;46:2339-2340.
     PubMed    
     
     
     
160. WANG X, Zheng Z, Chen G, Yu Q, et al
     Reply to: The impact of circumferential tumor location on the clinical outcomes of rectal cancers receiving neoadjuvant chemoradiation and surgery-does is really matter?
     Eur J Surg Oncol. 2020;46:2341-2342.
     PubMed    
     
     
     
161. BIRGISSON H, Enblad M, Artursson S, Ghanipour L, et al
     Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
     Eur J Surg Oncol. 2020;46:2283-2291.
     PubMed     Abstract available
     
     
     November 2020
162. GUSHCHIN V, Plerhoples T, Bijelic L
     Reply to: Letter to editor- "Minimally invasive surgery for T4 colon cancer is associated with better outcomes than open surgery in national cancer database".
     Eur J Surg Oncol. 2020 Nov 30. pii: S0748-7983(20)31037.
     PubMed    
     
     
     
163. VERKUIJL SJ, Jonker JE, Trzpis M, Burgerhof JGM, et al
     Functional outcomes of surgery for colon cancer: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2020 Nov 26. pii: S0748-7983(20)31032.
     PubMed     Abstract available
     
     
     
164. LURVINK RJ, Bakkers C, Rijken A, van Erning FN, et al
     Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
     Eur J Surg Oncol. 2020 Nov 26. pii: S0748-7983(20)31031.
     PubMed     Abstract available
     
     
     
165. KONSTANTINOU I, Shapey IM, Papamichael D, de Liguori Carino N, et al
     Outcomes following potentially curative therapies for older patients with metastatic colorectal cancer.
     Eur J Surg Oncol. 2020 Nov 12. pii: S0748-7983(20)30900.
     PubMed     Abstract available
     
     
     
166. BIRCH RJ, Downing A, Finan PJ, Howell S, et al
     Improving outcome prediction in individuals with colorectal cancer and diabetes by accurate assessment of vascular complications: Implications for clinical practice.
     Eur J Surg Oncol. 2020 Nov 3. pii: S0748-7983(20)30870.
     PubMed     Abstract available
     
     
     
167. ZHENG Z, Wang X, Huang Y, Lu X, et al
     Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
     Eur J Surg Oncol. 2020;46:2057-2063.
     PubMed     Abstract available
     
     
     
168. JONES HJS, Al-Najami I, Cunningham C
     Quality of life after rectal-preserving treatment of rectal cancer.
     Eur J Surg Oncol. 2020;46:2050-2056.
     PubMed     Abstract available
     
     
     
169. STERPETTI AV, Sapienza P, Fiori E, Marzo LD, et al
     Improved results for left-sided malignant colorectal obstruction with a proper selection for self expandable metal stent placement, surgical resection or diverting stoma.
     Eur J Surg Oncol. 2020;46:2064-2067.
     PubMed     Abstract available
     
     
     October 2020
170. HULSHOF EC, Lurvink RJ, Caserta N, de Hingh IHJT, et al
     Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
171. REIS ACV, Kusamura S, Azmi N, Fumagalli L, et al
     Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPEC.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
172. CHANG W, Liu T, Ren L, He G, et al
     A trinity technique for prevention of low rectal anastomotic leakage in the robotic era.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
173. GAO Z, Zhang D, Lei F, Zeng Q, et al
     Surgical treatment of massive stoma site tumors after a curative operation for rectal cancer.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
174. GUAN X, Lu Z, Wang S, Liu E, et al
     Comparative short- and long-term outcomes of three techniques of natural orifice specimen extraction surgery for rectal cancer.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
175. ZHANG Z, Cheng S, Gong J, Lu M, et al
     Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
176. REN C, Xu RH
     The drug treatment research of gastrointestinal cancer in China.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     September 2020
177. DIERS J, Baum P, Matthes H, Germer CT, et al
     Mortality and complication management after surgery for colorectal cancer depending on the DKG minimum amounts for hospital volume.
     Eur J Surg Oncol. 2020 Sep 25. pii: S0748-7983(20)30796.
     PubMed     Abstract available
     
     
     
178. NAGOURNEY RA, Evans S, Tran PH, Nagourney AJ, et al
     Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin.
     Eur J Surg Oncol. 2020 Sep 19. pii: S0748-7983(20)30789.
     PubMed     Abstract available
     
     
     
179. ZIMMITTI G, Panettieri E, Ardito F, Mele C, et al
     Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
     Eur J Surg Oncol. 2020 Sep 17. pii: S0748-7983(20)30782.
     PubMed     Abstract available
     
     
     
180. OW ZGW, Sim W, Nistala KRY, Ng CH, et al
     Comparing complete mesocolic excision versus conventional colectomy for colon cancer: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2020 Sep 12. pii: S0748-7983(20)30778.
     PubMed     Abstract available
     
     
     
181. EL-SHARKAWY F, Gushchin V, Plerhoples TA, Liu C, et al
     Minimally invasive surgery for T4 colon cancer is associated with better outcomes compared to open surgery in the National Cancer Database.
     Eur J Surg Oncol. 2020 Sep 10. pii: S0748-7983(20)30725.
     PubMed     Abstract available
     
     
     
182. RHAIEM R, Piardi T, Tashkandi A, Kianmanesh R, et al
     Is there a place for microwave ablation under Pringle maneuver for perivascular colorectal liver metastases?: Reponse to " Laparoscopic liver resection for liver tumors in proximity to major vasculature: A single-center comparative study".
     Eur J Surg Oncol. 2020;46:1766-1767.
     PubMed    
     
     
     
183. WILLEMS E, D'Hondt M
     Reply to: Is there a place for microwave ablation under Pringle maneuver for perivascular colorectal liver metastases?: Response to " Laparoscopic liver resection for liver tumours in proximity to major vasculature: A single-center comparative study".
     Eur J Surg Oncol. 2020;46:1768-1769.
     PubMed    
     
     
     
184. URSO EDL, Celotto F, Giandomenico F, Gavaruzzi T, et al
     Analysis of morbidity and mortality, quality of life and bowel function after total colectomy with ileorectal anastomosis versus right and left hemicolectomy: A study to optimise the treatment of lynch syndrome and attenuated polyposis coli.
     Eur J Surg Oncol. 2020;46:1613-1619.
     PubMed     Abstract available
     
     
     
185. HOLOWKO W, Triantafyllidis I, Neuberg M, Tabchouri N, et al
     Does the difficulty grade of laparoscopic liver resection for colorectal liver metastases correlate with long-term outcomes?
     Eur J Surg Oncol. 2020;46:1620-1627.
     PubMed     Abstract available
     
     
     
186. EDHEMOVIC I, Brecelj E, Cemazar M, Boc N, et al
     Intraoperative electrochemotherapy of colorectal liver metastases: A prospective phase II study.
     Eur J Surg Oncol. 2020;46:1628-1633.
     PubMed     Abstract available
     
     
     
187. VAN DER VALK MJM, van der Sande ME, Toebes RE, Breukink SO, et al
     Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?
     Eur J Surg Oncol. 2020;46:1634-1641.
     PubMed     Abstract available
     
     
     
188. ELFRINK AKE, Kok NFM, van der Werf LR, Krul MF, et al
     Population-based study on practice variation regarding preoperative systemic chemotherapy in patients with colorectal liver metastases and impact on short-term outcomes.
     Eur J Surg Oncol. 2020;46:1742-1755.
     PubMed     Abstract available
     
     
     
189. GAO X, Goffredo P, Kahl AR, Charlton ME, et al
     Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
     Eur J Surg Oncol. 2020;46:1663-1667.
     PubMed     Abstract available
     
     
     
190. HOENDERVANGERS S, Sparreboom CL, Intven MPW, Lange JF, et al
     The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
     Eur J Surg Oncol. 2020;46:1605-1612.
     PubMed     Abstract available
     
     
     
191. D'SOUZA N, Lord A, Shaw A, Patel A, et al
     The sigmoid take-off: An anatomical imaging definition of the rectum validated on specimen analysis.
     Eur J Surg Oncol. 2020;46:1668-1672.
     PubMed     Abstract available
     
     
     August 2020
192. LO DICO R, Faron M, Yonemura Y, Glehen O, et al
     Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI).
     Eur J Surg Oncol. 2020 Aug 26. pii: S0748-7983(20)30666.
     PubMed    
     
     
     
193. LORENZON L, Polom K
     Reply to: Tumour Biology and lack of standardization in assessment of ypT0 has an impact on survival in patients with locally advanced rectal cancers achieving complete pathological response after neoadjuvant chemoradiation.
     Eur J Surg Oncol. 2020;46:1562-1563.
     PubMed    
     
     
     
194. SPANNENBURG L, Sanchez Gonzalez M, Brooks A, Wei S, et al
     Surgical outcomes of colonic stents as a bridge to surgery versus emergency surgery for malignant colorectal obstruction: A systematic review and meta-analysis of high quality prospective and randomised controlled trials.
     Eur J Surg Oncol. 2020;46:1404-1414.
     PubMed     Abstract available
     
     
     July 2020
195. PANDEY D, Shinde R, Saklani A
     Tumour biology and lack of standardization in assessment of ypT0 has an impact on survival in patients with locally advanced rectal cancers achieving complete pathological response after neoadjuvant chemoradiation.
     Eur J Surg Oncol. 2020;46:1384-1385.
     PubMed    
     
     
     
196. YUVAL JB, Thompson HM, Firat C, Jimenez-Rodriguez RM, et al
     Confirmation of complete mesocolic excision with central vascular ligation.
     Eur J Surg Oncol. 2020;46:1386-1387.
     PubMed    
     
     
     June 2020
197. CYR DP, Zih FS, Wells BJ, Swett-Cosentino J, et al
     Long-term outcomes following salvage surgery for locally recurrent rectal cancer: A 15-year follow-up study.
     Eur J Surg Oncol. 2020;46:1131-1137.
     PubMed     Abstract available
     
     
     
198. KOMMALAPATI A, Tella SH, Yadav S, Goyal G, et al
     Survival and prognostic factors in patients with rectal squamous cell carcinoma.
     Eur J Surg Oncol. 2020;46:1111-1117.
     PubMed     Abstract available
     
     
     
199. REN L, Zhu D, Benson AB 3rd, Nordlinger B, et al
     Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019).
     Eur J Surg Oncol. 2020;46:955-966.
     PubMed     Abstract available
     
     
     
200. HAGEMANS JAW, Voogt ELK, Rothbarth J, Nieuwenhuijzen GAP, et al
     Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
     Eur J Surg Oncol. 2020;46:1160-1166.
     PubMed     Abstract available
     
     
     
201. WANG X, Chen G, Zhang Y, Ghareeb WM, et al
     The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
     Eur J Surg Oncol. 2020;46:1118-1123.
     PubMed     Abstract available
     
     
     May 2020
202. BARATTI D, Sammartino P, Kusamura S, Deraco M, et al
     Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases.
     Eur J Surg Oncol. 2020;46:737-739.
     PubMed    
     
     
     
203. DI MARTINO M, Rompianesi G, Mora-Guzman I, Martin-Perez E, et al
     Systematic review and meta-analysis of local ablative therapies for resectable colorectal liver metastases.
     Eur J Surg Oncol. 2020;46:772-781.
     PubMed     Abstract available
     
     
     
204. PROCOPIO F, Vigano L, Cimino M, Donadon M, et al
     Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study.
     Eur J Surg Oncol. 2020;46:818-824.
     PubMed     Abstract available
     
     
     
205. DI FRANCO G, Gianardi D, Palmeri M, Furbetta N, et al
     Pancreatic resections for metastases: A twenty-year experience from a tertiary care center.
     Eur J Surg Oncol. 2020;46:825-831.
     PubMed     Abstract available
     
     
     April 2020
206. KLOS D, Risko J, Krivackova D, Lovecek M, et al
     Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system - Single centre study.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
207. HENTZEN JEKR, van der Plas WY, Kuipers H, Ramcharan S, et al
     Delta peritoneal cancer index (DeltaPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
208. BHATT A, Yonemura Y, Mehta S, Benzerdjeb N, et al
     Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
209. SOMASHEKHAR SP, Yethadka R, Kumar C R, Ashwin KR, et al
     Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
210. D'HONDT M, Willems E, Parmentier I, Pottel H, et al
     Laparoscopic liver resection for liver tumours in proximity to major vasculature: A single-center comparative study.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     March 2020
211. ARSONIADIS EG, Finlayson E, Potenti F
     Is there a role for specialized geriatric centers in treating geriatric cancer patients?
     Eur J Surg Oncol. 2020;46:383-386.
     PubMed     Abstract available
     
     
     
212. SEVAK S, Gregoir T, Wolthuis A, Albert M, et al
     How can we utilize local excision to help, not harm, geriatric patients with rectal cancer?
     Eur J Surg Oncol. 2020;46:344-348.
     PubMed     Abstract available
     
     
     
213. HAAK HE, Maas M, Lambregts DMJ, Beets-Tan RGH, et al
     Is watch and wait a safe and effective way to treat rectal cancer in older patients?
     Eur J Surg Oncol. 2020;46:358-362.
     PubMed     Abstract available
     
     
     
214. ASOGLU O, Tokmak H, Bakir B, Demir G, et al
     The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases.
     Eur J Surg Oncol. 2020;46:402-409.
     PubMed     Abstract available
     
     
     
215. MILLAN M, Renau-Escrig AI
     Minimizing the impact of colorectal surgery in the older patient: The role of enhanced recovery programs in older patients.
     Eur J Surg Oncol. 2020;46:338-343.
     PubMed     Abstract available
     
     
     
216. MYINT AS, Gerard JP
     Role of radiotherapy in the treatment of rectal cancer in older patients.
     Eur J Surg Oncol. 2020;46:349-357.
     PubMed     Abstract available
     
     
     
217. KOLARSICK PA, Sacchi M, Spinelli A, Wexner SD, et al
     Minimizing the impact of colorectal surgery in the older patient: The role of minimally invasive surgery in the geriatric population.
     Eur J Surg Oncol. 2020;46:333-337.
     PubMed     Abstract available
     
     
     
218. DETERING R, de Neree Tot Babberich MPM, Bos ACRK, Dekker JWT, et al
     Nationwide analysis of hospital variation in preoperative radiotherapy use for rectal cancer following guideline revision.
     Eur J Surg Oncol. 2020;46:486-494.
     PubMed     Abstract available
     
     
     
219. DENOST Q, Bousser V, Morin-Porchet C, Vincent C, et al
     The development of a regional referral pathway for locally recurrent rectal cancer: A Delphi consensus study.
     Eur J Surg Oncol. 2020;46:470-475.
     PubMed     Abstract available
     
     
     
220. HAGEMANS JAW, van Rees JM, Alberda WJ, Rothbarth J, et al
     Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre.
     Eur J Surg Oncol. 2020;46:448-454.
     PubMed     Abstract available
     
     
     
221. LORENZON L, Evrard S, Beets G, Gonzalez-Moreno S, et al
     Global variation in the long-term outcomes of ypT0 rectal cancers.
     Eur J Surg Oncol. 2020;46:420-428.
     PubMed     Abstract available
     
     
     
222. BASHIR MOHAMED K, Hansen CH, Krarup PM, Fransgard T, et al
     The impact of anastomotic leakage on recurrence and long-term survival in patients with colonic cancer: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2020;46:439-447.
     PubMed     Abstract available
     
     
     
223. FAHIM M, Dijksman LM, van Kessel CS, Smeeing DPJ, et al
     Promising results of a new treatment in patients with bowel obstruction in colorectal surgery.
     Eur J Surg Oncol. 2020;46:415-419.
     PubMed     Abstract available
     
     
     
224. ZHANG YX, Liu HY, Jiang B, Wang WY, et al
     Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
     Eur J Surg Oncol. 2020;46:410-414.
     PubMed     Abstract available
     
     
     
225. ROSTOFT S, Hamaker ME
     Basic geriatric principles for colorectal surgeons: How to optimize assessment and care of older patients in the perioperative period.
     Eur J Surg Oncol. 2020;46:310-315.
     PubMed     Abstract available
     
     
     
226. SHAHROKNI A, Alexander K
     What will perioperative geriatric assessment for older cancer patients look like in 2025? Advantages and limitations of new technologies in geriatric assessment.
     Eur J Surg Oncol. 2020;46:305-309.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: